Third-party disease pages (diabetes, thyroid, PCOS, kidneys, arthritis): Tayebat principles may help these conditions as an educational, supportive approach under medical supervision; they do not replace treatment.

Original statement

لا تطبّق الطيبات كاملاً دون طبيب كلى.

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Third-party disease pages (diabetes, thyroid, PCOS, kidneys, arthritis): Tayebat principles may help these conditions as an educational, supportive approach under medical supervision; they do not replace treatment.

Origin

Source status

Third-party site (unofficial)

Attribution

Third-party site (unofficial)

Origin

https://mytayibat.com/mytayibat-kidneys

Attribution uncertainty

Disease pages fetched 2026-10-25 (diabetes, thyroid, PCOS, kidneys, arthritis); not Elawady's words. mytayibat.com is an unofficial third-party site in the sense that it is neither the eltayebat.com archive nor Elawady's own words. Its footer describes it as 'المنصة الرسمية التعليمية لنظام الطيبات' ('the official educational platform of the Tayebat system'), and its pages refer to it as 'the official platform'. This self-description could not be verified: no evidence was found that the site is authorised by Dr. Diaa Elawady's heirs or by the eltayebat.com archive. By contrast, altayybat.com states that it is not affiliated with Dr. Diaa Elawady. Lowest attribution level; page fetched 2026-10-25.

Population concerned

People with chronic conditions

Geographic restriction by Elawady

none found

Diverging source versions

Scientific assessment

Unclear / insufficient evidence – The data do not allow an assessment either way.

Certainty of evidence: very low – Any assessment is very uncertain.

1. What was claimed?

Tayebat may support management of diabetes, thyroid disease, PCOS, kidney disease and arthritis when coordinated with physicians.

2. What is demonstrably correct?

The pages do NOT claim cures. They advise not changing insulin or drug doses without a doctor (diabetes), coordinating with endocrinologists (thyroid, PCOS), not applying the full system without a nephrologist (kidneys), and not stopping medicines (arthritis). Reducing processed food and soft drinks is reasonable general advice.

3. What is wrong or exaggerated?

Mechanistic statements attributed to Elawady on these pages (e.g., 'reducing heavy food lowers silent inflammation') are not supported by cited evidence; the arthritis page forbids legumes, refined bread and liquid dairy without evidence for joint outcomes.

4. What remains unclear?

Effect of the system on any of these conditions.

5. Which studies support it?

Partly: the ADA Standards of Care 2026 recommend individualised medical nutrition therapy, minimising sugar-sweetened beverages, refined grains, processed and ultra-processed foods, and medical oversight with possible adjustment of insulin and other medicines when diets change (I-INTC-03). This matches the pages' advice to coordinate with physicians.

6. Which studies contradict it?

The same guideline recommends eating patterns that include nonstarchy vegetables, whole fruits, legumes, whole grains and low-fat dairy (I-INTC-03), several of which the Tayebat lists exclude. No trial of the Tayebat system for diabetes, thyroid disease, PCOS, kidney disease or arthritis was found.

7. What applies to Germany and Europe?

European diabetes care also individualises nutrition therapy (EASD/ADA consensus, not audited here). No European guideline recommends the Tayebat system.

8. What is known about Egypt?

The pages are written for Arabic-speaking, largely Egyptian readers; no Egyptian data on outcomes of the system were found.

9. What practical conclusion is appropriate?

Any dietary change for these conditions should be coordinated with the treating physician, as the pages themselves say.

Assessment details

Rationale for certainty of evidence

No trial of the Tayebat system for any of these conditions was found. The cautious advice on the pages (medical supervision, no change of medicines without a doctor) is consistent with the ADA Standards of Care 2026 (I-INTC-03), but the food exclusions partly conflict with guideline-recommended eating patterns.

Source quality

Third-party site.

Regional scope of the claim

general (biological/medical)

Last reviewed

25 October 2026 provisional

In plain language

A third-party website has pages on Tayebat and diabetes, thyroid, PCOS, kidney disease and arthritis. These pages do not promise cures and repeatedly tell readers not to change medicines without their doctor. There is no study testing the system for these diseases. This cautious tone differs from many statements in Dr. Diaa's videos.

Studies on this claim

Regional context

Germany / EU

European diabetes care also individualises nutrition therapy (EASD/ADA consensus, not audited here). No European guideline recommends the Tayebat system.

Egypt

The pages are written for Arabic-speaking, largely Egyptian readers; no Egyptian data on outcomes of the system were found.

• Food-safety governance and official controls
• Import controls and the meaning of RASFF notifications for Egyptian products

What applies in my country?

General scientific assessment

Unclear / insufficient evidence The third-party disease pages are cautious and make no cure claims; benefit is unproven.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

1. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee. Diabetes Care 2026 · PMID 41358898 · DOI 10.2337/dc26-S005